MNKD:NASDAQ
MannKind Corp
$4.25
arrow_upward
+0.71%(+0.030) 1D
$4.21
arrow_downward
-0.94% (-0.040)bedtimePagkalipas ng oras ng trabaho
Sarado: Hul 8, 4:00:00 PM GMT-4 · USD
search
Lahat ng simbolo
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa MNKD...
Buksan
$4.16
Mataas
$4.32
Mababa
$4.07
Mkt. cap
1.31B
Avg. na dami
5.61M
Dami
6.89M
Mataas nang 52-wk
$6.51
Mababa nang 52-wk
$2.23
EPS
-$0.08
Beta
1.09
Mga natitirang share
308.95M
Bilang ng mga empleyado
592
Buksan
$4.16
Mataas
$4.32
Mababa
$4.07
Mkt. cap
1.31B
Avg. na dami
5.61M
Dami
6.89M
Mataas nang 52-wk
$6.51
Mababa nang 52-wk
$2.23
EPS
-$0.08
Beta
1.09
Mga natitirang share
308.95M
Bilang ng mga empleyado
592
Mga balita at kwento
Mula sa mga source sa buong web
https://www.dars.gov.et/
·
1 buwan ang nakalipas
MNKD Q1 2026 Earnings: Significant EPS Miss Amidst Revenue Uncertainty - Share Dilution Risk
Profile
MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991.
MannKind Corporation was named after its founder, Alfred E. Mann. Wikipedia
Tungkol sa MannKind Corp
CEOMichael Castagna
Mga Empleyado592
ItinatagPeb 1991
HeadquartersDanbury, Connecticut, Estados Unidos
Sektor-
Websitemannkindcorp.com
Posibleng magkaroon ng mga pagkakamali ang AI content. Matuto pa